Adimab Reports Strong Partnering Year for 2025
– 23 Overall Partnerships in 2025 – – 75 New Programs Added in 2025 – – 50 Milestones Achieved in…
Read More
The Times Of Bengal
For You Forever Yours
What’s Really In Your Shilajit Supplements? Pürblack Calls Out Counterfeit Products
Many shilajit products prioritize taste over function: Pürblack urges consumers to look beyond marketing claims and demand real efficacy from…
Read More
Catalight and Frontera Partner to Reduce Cost and Improve Quality of Autism Care
Catalight will provide access to Frontera technology through its provider network DENVER and WALNUT CREEK, Calif., Jan. 12, 2026 /PRNewswire/…
Read More
Community Autism Services Opens New Autism Learning Center in Haverhill
HAVERHILL, Mass., Jan. 12, 2026 /PRNewswire/ — Community Autism Services is proud to announce the grand opening of a new…
Read More
Boehringer Ingelheim and CommonSpirit Health Collaborate to Improve Cardio-Kidney-Metabolic Screening and Diagnosis in Vulnerable Populations
A strategic partnership with CommonSpirit Health aims to increase adherence to evidence-based guidelines (EBGs), improving screening and diagnosis of cardio-kidney-metabolic…
Read More
Health Enterprise Partners Appoints Healthcare Industry Veteran Roland Lyon as Operating Partner
NEW YORK, Jan. 12, 2026 /PRNewswire/ — Health Enterprise Partners (“HEP”), a leading healthcare-focused private equity firm, today announced that…
Read More
Fine Fettle Will Expand Medical Access Across Connecticut by Converting All Locations to Hybrid Dispensaries on Jan. 15
All nine Fine Fettle cannabis dispensary locations will serve both medical patients and adult-use customers following a new Connecticut law.…
Read More
n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases
SAN DIEGO and GENEVA, Jan. 12, 2026 /PRNewswire/ — The n-Lorem Foundation and the EspeRare Foundation announced today a strategic…
Read More
PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics
BELFAST, Northern Ireland , Jan. 12, 2026 /PRNewswire/ — PulseAI, a rapidly emerging leader in AI-enabled cardiac diagnostics, today announced…
Read More
Curasight Announces Encouraging Preliminary Data from Phase 1 Trial Evaluating First-in-Class Radiopharmaceutical uTREAT in High-Grade Gliomas®
Clear uptake of uTREAT® in aggressive brain cancer (glioblastoma) Early data support the potential of first-in-class uPAR-targeted theranostic approach to…
Read More
